Bioglutide ntsiav tshuaj

Shaanxi BLOOM Tech Co., Ltd. yog ib qho ntawm cov tuam ntxhab thiab cov muag khoom ntawm Bioglutide Tablets hauv Suav teb. Txais tos rau cov lag luam wholesale bulk zoo Bioglutide ntsiav tshuaj muag ntawm no los ntawm peb lub hoobkas. Kev pabcuam zoo thiab tus nqi tsim nyog muaj.

Bioglutide ntsiav tshuaj,qhov ncauj me me -molecule quadruple receptor agonist, muaj txiaj ntsig zoo hauv kev noj qab haus huv metabolic thaum ua kom pom lub peev xwm tshwj xeeb rau kev cuam tshuam kev nyuaj siab. Los ntawm ntau- txoj hauv kev sib koom ua ke, nws hloov pauv kev xav- ntsig txog cov txheej txheem physiological los ntawm kev tiv thaiv cov neurons ncaj qha, tswj cov kab mob neuroinflammation thiab kev ntxhov siab, thiab txhim kho lub hlwb metabolism. Nws kuj tseem cuam tshuam rau lub plab- lub hlwb axis los cuam tshuam lub plab noj qab haus huv thiab kev taw qhia, thaum txhim kho cov metabolism hauv lub cev kom tawg lub voj voog "metabolic dysfunction-inflammation-depression". Tshwj xeeb yog tsim nyog rau cov neeg mob kev nyuaj siab nrog kev rog rog lossis glycemic instability, nws muab ob qho txiaj ntsig ntawm kev tiv thaiv kab mob neuroprotection thiab metabolic txhim kho, muab txoj hauv kev tshiab rau kev tswj hwm kev ntxhov siab dhau ib zaug - cov kev cuam tshuam ntawm cov txheej txheem.

 

Peb cov khoom

 

Bioglutide NA-931 COA

I. Formulation and Pharmacokinetic Advantages

1. Oral Small Molecule Design: Tsis zoo li GLP-1 receptor agonists (xws li semaglutide thiab tirzepatide), kev tswj qhov ncauj kom tsis txhob muaj qhov khaus hauv zos cuam tshuam nrog cov ntsiav tshuaj. Tsis tas li ntawd, cov tshuaj ntshav ntshav nce ntxiv tsis tu ncua yam tsis muaj qhov nce siab tom qab txhaj tshuaj, uas tiv thaiv kev mob plab zom mov.
2. Kev ywj pheej ntawm zaub mov thiab nqus tau qhov profile: Nws qhov nqus ntawm qhov ncauj tsis cuam tshuam los ntawm kev noj zaub mov, tshem tawm qhov xav tau kev yoo mov thaum lub sijhawm tswj hwm. Qhov no txo ​​qis plab hnyuv tsis xis nyob los ntawm kev sib cuam tshuam ntawm kev noj haus thiab tshuaj thaum txhim kho yooj yim thiab kam rau ua.

3. Kev Tswj Xyuas Kev Noj Qab Haus Huv Me Me: Piv rau qee qhov ntev - cov tshuaj txhaj tshuaj uas ua rau lub plab zom mov qeeb (xws li, semaglutide tuaj yeem ua rau lub plab khoob ntev dua 12 teev),Bioglutide ntsiav tshuajexerts ib tug softer gastrointestinal tswj nyhuv, txo qhov tshwm sim ntawm cov tsos mob xws li tsam plab thiab xeev siab.

 

 

II. Clinical pov thawj thiab Dosing Strategy

1. Phase II Clinical Data Support: Hauv pawg koob tshuaj 150 mg, qhov tshwm sim ntawm xeev siab thiab ntuav tshaj 13 lub lis piam yog 7.3%, thiab raws plab yog 6.3%. Cov nqi no tseem qis dua li qee qhov kev txhaj tshuaj hnyav- cov tshuaj poob (piv txwv li, qhov tshwm sim tsis zoo hauv plab hnyuv siab tshaj 80% hauv pawg semaglutide 2.4 mg koob tshuaj). Tsis tas li ntawd, tsis muaj kev phiv loj heev tau tshaj tawm, thiab kev txiav tawm tsis zoo.

2. Tsawg-Kev pib koob tshuaj thiab Titration: Lub tswv yim kho mob yuav tsum pib nrog cov koob tshuaj qis thiab maj mam kho nws, ua rau lub cev hloov pauv mus rau cov tshuaj cuam tshuam. Txoj hauv kev no txo ​​qis kev pheej hmoo ntawm kev mob plab hnyuv thiab muaj kev tiv thaiv zoo dua piv rau qee qhov kev txhaj tshuaj pib ntawm koob tshuaj ntau dua.

Bioglutide ntsiav tshuaj(NA-931) tsis yog tsuas yog kev tshawb nrhiav tshuaj kho mob nkaus xwb tab sis kuj yog lub cuab yeej tseem ceeb thiab kev siv thev naus laus zis hauv kev txhim kho cov kab mob metabolic.

I.Validation of Drug Delivery and Formulation Technology: A Benchmark for Oral Metabolic Drug Formulation Optimization

Cov yam ntxwv ntawm lub qhov ncauj ntawm nws muab cov txheej txheem tseem ceeb rau kev txhim kho ntawm qhov ncauj me me -molecule peptide / metabolic modulator formulations, suav nrog:

Kev Qhia Txog Kev Txhim Kho Oral Bioavailability:Cov tshuaj me me - cov tshuaj molecule metabolic feem ntau ntsib cov teeb meem xws li kev nqus ntawm plab hnyuv tsis zoo thiab tseem ceeb ua ntej - cuam tshuam. Los ntawm kev tsim kho kom zoo, Nws ua tiav qhov ncauj bioavailability ruaj khov yam tsis muaj kev vam khom rau kev nqus (piv txwv li, SNAC). Nws cov qauv tsim, kev xaiv cov khoom noj khoom haus, thiab cov tswv yim kev ruaj ntseg hauv plab tuaj yeem ua haujlwm ncaj qha los ntawm kev siv rau kev txhim kho qhov ncauj bioavailability ntawm lwm yam me me -cov tshuaj molecule metabolic, hais txog qhov tseem ceeb hauv kev tswj hwm qhov ncauj.

Kev lees paub ntawm Khoom Noj -Kev ywj pheej Dosing Formulation Logic:GLP qhov ncauj uas twb muaj lawm-1 tshuaj (piv txwv li, cov ntsiav tshuaj ntawm qhov ncauj semaglutide) yuav tsum tau yoo mov rau kev tswj hwm, txwv kev ua raws li tus neeg mob. Bioglutide qhov ncauj nqus yog tsis cuam tshuam los ntawm kev noj zaub mov. Nws txoj kev tsim qauv zam kev cuam tshuam los ntawm cov khoom noj ntawm cov tshuaj yaj yeeb thiab nqus, ua pov thawj qhov ua tau ntawm "cov khoom noj tsis txaus ntawm qhov ncauj." Qhov no muab cov qauv tsim kev pom zoo rau kev tsim cov tshuaj uas muaj cov tshuaj metabolic hauv qhov ncauj thiab ua kom cov neeg mob tau txais kev kho mob zoo dua.

 

 

Technology Exploration Platform rau Ntev -Tsev Cov Qauv Hauv Qhov Ncauj

Nws txhawb nqa ib zaug - noj qhov ncauj txhua hnub. Nws cov thev naus laus zis tsim los tswj hwm hauv vivo ib nrab- lub neej thiab kev tswj cov ntshav cov tshuaj kom ruaj khov tuaj yeem siv los tshawb nrhiav kev txhim kho ntev - ua yeeb yam hauv qhov ncauj cov tshuaj metabolic (piv txwv li, ib zaug- cov ntaub ntawv noj qhov ncauj txhua lub lim tiam). Qhov no ua haujlwm raws li kev siv thev naus laus zis thev naus laus zis txhawm rau kov yeej kev lag luam fwj ntawm qhov ntev - ua yeeb yam tshuaj tiv thaiv luv luv - ua yeeb yam ntawm qhov ncauj.

II.Industrial thiab kev kawm ntawv tus nqi

Cov Tswv Yim Ua Lag Luam Ua Lag Luam Ua Raws Cai rau GLP-1 Cov Tshuaj Tom Qab Daim Ntawv Pov Thawj Daim Ntawv Pov Thawj

Core patents ntawm loj GLP-1 receptor agonists (xws li semaglutide thiab liraglutide) yuav maj mam tas mus li, ua kom muaj kev sib tw los ntawm cov tshuaj generic. Kev sib xyaw ua ke ntawm kev kho mob patents rau qhov no nrog cov tshuaj no muab cov kev daws teeb meem raws li "tsawg-cov tshuaj pib siv tshuaj + cov tshuaj ntau lub hom phiaj".

Txoj hauv kev no tsis yog tsuas yog zam kev sib tw nqi ntawm cov khoom lag luam tab sis kuj ua tiav cov khoom sib txawv los ntawm kev txhim kho kev ua tau zoo thiab kev nyab xeeb, muab txoj hauv kev ua lag luam rau ob qho tib si hauv paus thiab cov tuam txhab tshuaj tshiab tom qab patent tas sij hawm.

III.Core Experimental Carrier rau Metabolic Biology Fundamental Research

Bioglutide ntsiav tshuaj, raws li ib qho tshwj xeeb ntau- lub hom phiaj cov cuab yeej molecule, ua haujlwm tseem ceeb hauv cov txheej txheem metabolic thiab kev tshawb fawb tshuaj pharmacological. Nws cov txiaj ntsig tseem ceeb ntawm kev kawm yog tshwm sim hauv cov hauv qab no:

 

 

Cov cuab yeej tshawb fawb rau Crosstalk Ntawm Metabolic Pathways

Cov kab mob metabolic cuam tshuam nrog dysregulation hla ntau txoj hauv kev taw qhia. Nws tuaj yeem ua kom muaj plaub txoj hauv kev metabolic, ua rau nws yog ib qho cuab yeej tseem ceeb rau kev kawm crosstalk ntawm txoj hauv kev no (xws li, kev sib koom ua ke ntawm GLP-1 thiab IGF-1 txoj hauv kev ntawm cov leeg nqaij metabolism, thiab kev tswj hwm kev sib raug zoo ntawm glucagon thiab GIP txoj hauv kev lipolysis). Qhov no pab qhia cov kab mob ntawm cov kab mob xws li rog rog, ntshav qab zib hom 2, thiab MASH, ua kom muaj qhov sib txawv ntawm cov cuab yeej rau kev kawm ntau txoj hauv kev sib koom ua ke.

Kev Tshawb Fawb Qauv rau Receptor Pharmacology thiab Kev Hloov Pauv Hloov
Raws li cov cuab yeej molecule, Bioglutide ua rau txoj kev tshawb fawb ntawm kev sib xyaw ua ke ntawm G protein-coupled receptors (GPCRs, suav nrog GLP-1, GIP, thiab glucagon receptors) thiab IGF-1 receptors. Nws pab hauv kev txheeb xyuas qhov ua kom kinetics ntawm cov receptors sib txawv, sib tham ntawm cov kev taw qhia hauv qab, thiab lub hauv paus molecular ntawm kev tsis ncaj ncees lawm. Qhov no muab cov qauv kev sim rau receptor pharmacology thiab cov qauv kev tshawb fawb txog biology, tsav cov theoretical breakthroughs hauv GPCR tsev neeg kev txhim kho tshuaj.

Bridging Molecule rau Clinical Translation Research

Nrog cov ntaub ntawv dav dav dav los ntawm kev tshawb fawb ua ntej mus rau Phase II kev sim tshuaj ntsuam xyuas, nws tsim kom muaj kev sib txuas lus txuas nrog "kev tshawb fawb txog kev siv tshuab rau kev soj ntsuam kev ua tau zoo." Nws tuaj yeem siv los txheeb xyuas kev sib raug zoo ntawm cov phiaj xwm txheej txheem thiab cov chaw kho mob kawg, kev sib raug zoo ntawm cov tshuaj pharmacokinetics thiab pharmacodynamics, thiab kev tshuaj ntsuam xyuas kev nyab xeeb biomarkers. Qhov no muab cov ntaub ntawv muaj zog txhawb rau kev tshawb fawb soj ntsuam kev txhais lus ntawm cov tshuaj metabolic, ua kom nrawm rau kev txhais lus ntawm cov kev tshawb fawb tshawb fawb hauv kev siv tshuaj kho mob.

 

 

Bidirectional Regulation Pathways of Emotion and Metabolism

Kev nyuaj siab feem ntau nrog rau kev cuam tshuam hauv lub hlwb -gut axis. Qhov no ua tiav kev hloov pauv bidirectional los ntawm cov txheej txheem hauv qab no:

1. Sib npaug ntawm Enteric Neurotransmitters
Txhawb nqa qhov tso tawm ntawm 5-HT los ntawm plab hnyuv L- hlwb, uas nkag mus rau hauv nruab nrab lub paj hlwb los ntawm cov hlab ntsha thiab cov hlab ntsha vagus, nce 5-HT qib hauv raphe nuclei thiab ua rau SSRI zoo li cov tshuaj tiv thaiv kev nyuaj siab.

Inhibits plab hnyuv o thiab txo cov hnyuv permeability, yog li txo LPS nkag mus rau hauv cov hlab ntsha, txo cov kab mob inflammatory load, thiab indirectly ameliorating central neuroinflammation.

2. Microbiota-Metabolite-Brain Signaling
Modulates cov muaj pes tsawg leeg ntawm lub plab microbiota, ua kom cov kab mob muaj txiaj ntsig zoo xws li * Akkermansia*, uas txhim kho cov khoom luv luv - chain fatty acids (SCFAs). SCFAs hla cov ntshav- hlwb teeb meem los tswj neuroinflammation thiab neurotransmitter synthesis.Txhim kho plab hnyuv motility thiab assorption assorption, txo kev puas siab puas ntsws ntxhov siab vim los ntawm gastrointestinal tsis xis nyob, li no pab txhawb tag nrho cov tolerability thiab kev xav stability.

Kev sib xyaw ntawm Metabolism Inflamation Neuroplasticity: Tag Nrho Cov nyhuv ntawm Antidepressants

Txhim kho Insulin Resistance thiab Ntshav Qab Zib Fluctuations:Txo cov neuroinflammation thiab neuronal puas tsuaj los ntawm qhov txawv txav hauv nruab nrab qabzib metabolism, yog li rov ua kom cov metabolism hauv homeostasis hauv hippocampus (piv txwv li, qib NAA thiab glutamate).

Modulates lub Tryptophan-Kynurenine Txoj Kev:Txo cov kev tsim cov neurotoxic metabolites (xws li quinolinic acid) thiab ua rau kom muaj tryptophan, ib qho precursor rau 5-HT synthesis.

Txo kev ntxhov siab -Induced Cortisol Elevation:Txo glucocorticoid toxicity rau hippocampal neurons, txhim kho kev ntxhov siab hloov thiab ua kom muaj zog.

Tswj Pw tsaug zog-Wake Cycles:Alleviates pw tsaug zog mob txuam nrog kev nyuaj siab thiab restores stability ntawm circadian rhythms.

• Puas yog cov tshuaj no zoo ib yam li semaglutide?

Tsis txhob cuam tshuam nrog GLP-1 receptor agonists uas twb muaj lawm (xws li semaglutide thiab tilpotide), vim tias lawv muaj qhov sib txawv tseem ceeb hauv kev sib xyaw, kev pom zoo, thiab siv.

• Cov teebmeem ntawm Bioglutide yog dab tsi?

Cov kev mob tshwm sim tshwm sim nyob rau hauv kev tshawb fawb soj ntsuam muaj xws li cov leeg nqaij spasms, raws plab, thiab pob txuv.

• Yuav ua li cas txo cov kev mob tshwm sim ntawm nws?

Xaiv lub teeb, tsawg- rog, yooj yim digestible zaub mov, xws li oats, steamed taub dag, porridge, thiab zaub siav. Tsis txhob ntsim, kib, qab zib, thiab cov khoom noj siv mis kom txo tau cov hnyuv. Kev siv cov qauv me me thiab nquag noj mov (5-6 pluas noj ib hnub) kom txo tau lub plab zom mov.

Cim npe nrov: Bioglutide ntsiav tshuaj, lwm tus neeg, manufacturers, hoobkas, lag luam wholesale, yuav, nqe, tej, kev muag khoom